A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer Meeting Abstract


Authors: Yee, L.; Lynch, T.; Villalona-Calero, M.; Rizvi, N.; Gabrail, N.; Sandler, A.; Cropp, G.; Palmer, G.
Abstract Title: A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 652S
Language: English
ACCESSION: WOS:000230326604242
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.7127
Notes: --- - Meeting Abstract: 7127 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi